Pharmacist Digest

Electronic Tablet Counter with Automated Feed Control

PharmaTech

MAY 1, 2024

Deitz’s Pharmafill TC4 tabletop tablet counter is suitable for counting and filling capsules, gelcaps, pills, softgels, and other opaque, translucent, and transparent oral solid dosage forms.

Dosage

Pharmacy professionals invited to feed back on National Care Records Service

The Pharmacist

APRIL 18, 2023

In addition to accessing a patient’s Summary Care Record, the new service also allows pharmacy professionals that can already access SCR – that is, pharmacists and pharmacy technicians registered […] The post Pharmacy professionals invited to feed back on National Care Records Service appeared first on The Pharmacist.

Pharmacy Technician

A study says intermittent fasting is making people drop dead. Oh, come on

STAT

MARCH 19, 2024

The news is everywhere in my social news feeds this morning: A popular fad diet is apparently lethal, scientific research says. Specifically, a study found that caloric restriction, also known as intermittent fasting, has a 91% risk of death due to cardiovascular disease.

STAT+: In small study, baby aspirin cuts fat buildup in liver disease patients

STAT

MARCH 19, 2024

The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring. MASLD ( formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver.

Medical Schools

Medical Schools Hospitals

Believe the hype? Mixed signals from AI’s impact on drug development

PharmaVoice

JANUARY 10, 2024

Although AI’s failure rates in drug development still leave room for improvement, today’s missteps feed tomorrow’s successes.

Drug Development

STAT+: He’s 19 months old and has one of the world’s rarest diseases. His parents are determined to find a cure.

STAT

MARCH 4, 2024

He gets most of his nutrition through a feeding tube attached to his belly. SOMERVILLE — At 19 months old, Lucas Guo has never crawled, walked, or stood by himself. He babbles but can’t say words. He struggles to chew and swallow.

Documentation

Q&A: Why Dynamic Data Feeds are Critical for Successful Commercial Machine Learning Models

PharmExec

MARCH 31, 2023

Indegene's Jitesh Sah, Vice President, Analytics and Vikas Mahajan, Sr. Director, Data & Analytics chat with senior editor Fran Pollaro about the challenge of data drift.

Opinion: Having a child with complex medical needs is hard enough. Navigating the health care system makes it worse

STAT

DECEMBER 7, 2023

Alongside their custom car seats, our patients leave with tracheostomies, life-sustaining ventilators, oxygen tanks, suction machines, feeding tubes and pumps, and discharge instructions the size of a textbook — all necessary items to start their journey outside the hospital.

Hospitals

STAT+: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives

STAT

MARCH 20, 2024

She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. Every morning, Victoria Rasberry gets up before 6 a.m.,

Drug Pricing

STAT+: New weight loss drugs are changing the narrative on obesity, with a push from pharma

STAT

MARCH 5, 2023

A two-part message is permeating the halls of medicine and the fabric of society, sliding into medical school lectures, pediatricians’ offices, happy hours and social feeds: Obesity is a chronic biological disease — and it’s treatable with a new class of medications. Continue to STAT+ to read the full story…

Medical Schools

Medical Schools Drug Development Diabetes

France’s biotech ecosystem is primed for growth – it’s time to feed it

pharmaphorum

SEPTEMBER 13, 2021

The post France’s biotech ecosystem is primed for growth – it’s time to feed it appeared first on. She was recently appointed by the French government to promote the country’s biotech ecosystem internationally.

STAT+: FDA cites cancer links in seeking to withdraw approval of antibiotic used in pigs

STAT

NOVEMBER 7, 2023

At issue is carbadox , which, since the 1970s, has been added to livestock feed to combat diarrhea in young pigs after they are weaned from their mothers, as well as to promote growth.

STAT+: UPMC, Advocate Aurora, Duke fighting lawsuits over use of Meta’s tracking tool

STAT

NOVEMBER 23, 2022

Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information through a tracking tool on their websites, prominent systems like UPMC, Advocate Aurora, and Duke Health are still contending with the resulting legal action.

Hospitals

STAT+: Revenue cycle management company Waystar files for IPO

STAT

OCTOBER 17, 2023

It also feeds the data to its machine learning and AI algorithms to improve the Waystar software. It handles everything from patient onboarding to prior authorization to payment collection for providers that include hospitals, physician practices, and surgery centers. Continue to STAT+ to read the full story…

Hospitals

STAT+: NIH halts funding for Colombian research facilities accused of abusing animals

STAT

JULY 5, 2023

The group alleged the research facilities violated numerous animal welfare laws and regulations, such as failing to have procedures to take care of the monkeys, feeding the animals an inappropriate diet, confining them in cages covered with feces, failing to maintain proper records, and failing to have a veterinarian on staff.

Vaccines

Opinion: What ‘The Bear’ can teach us about hospitality in medicine

STAT

AUGUST 8, 2023

They do background checks on diners, scan their social media feeds, and generally eavesdrop and actively listen to find any hint or clues of what will make these peoples’ day. “Every day here is the freakin’ Super Bowl,” Richie’s handler, Garrett, explains.

Hospitals

Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act

Drug Channels

MAY 2, 2024

This Feed is for personal non-commercial use only. ET for a free online panel discussion about how brands can continue to offer robust patient support despite IRA challenges. Read on for Chris’ insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

APRIL 12, 2024

This Feed is for personal non-commercial use only. To learn more about enhancing patient engagement and adherence, download CareMetx's new report: Driving Brand Success: Minimize Risk and Capture Missed Value from Patient Engagement and Adherence. Read on for Jessica’s insights. All rights reserved.

CVM Relaxes Its Stance on Claims for Food Ingredient; Opening the Door for (Some) Novel Food Ingredients

FDA Law Blog: Biosimilars

FEBRUARY 21, 2024

The PPM has severely limited development of new animal feed ingredients, including ingredients that promote growth, productivity claims, and ingredients with benefits for the environment. As reported previously, the Innovative Feed Enhancement and Economic Development Act ( H.R.6687 6687 and S.

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels

MARCH 28, 2024

This Feed is for personal non-commercial use only. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Solving Access Barriers in Biomarker Testing: 5 Tips for Manufacturers

Drug Channels

MAY 9, 2024

This Feed is for personal non-commercial use only. To learn more about navigating the complexities of market access, contact MMIT and its sister company, The Dedham Group. Read on for their insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

APRIL 9, 2024

This Feed is for personal non-commercial use only. Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update

Drug Channels

MAY 7, 2024

This Feed is for personal non-commercial use only. But until anyone takes action, we will continue to live with the golden rule of the drug channel: Whoever has the gold gets to make the rules. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Specialty Pharmacies

Three Digital Intake Strategies For Eliminating Patient Enrollment Forms

Drug Channels

MARCH 22, 2024

This Feed is for personal non-commercial use only. To learn about AssistRx’s digital intake solutions, download Digital Intake for Specialty Drug Programs: Q1 2024 Progress Report. Read on for Adam’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies

Enteral Administration Reference

RX Note

OCTOBER 19, 2023

Some of them may have swallowing difficulty or are on enteral feeding tube. There are few references that specifically provide a quick answer on whether a drug can be administered by enteral feeding tube or not. some medications should not be altered due to some reasons). some medications should not be altered due to some reasons).

Hospitals

Pharmacists surveyed on prescription charges

The Pharmacist

JANUARY 16, 2024

The survey will feed into the coalition’s ongoing campaign to have prescription charges scrapped for people with long-term conditions in England. Pharmacists have been asked to share their experience of patients refusing prescriptions due to cost, as part of a survey launched by the Prescription Charges Coalition.

Novartis' Zolgensma shows 'continued benefit' in SMA patients

Pharma Times

OCTOBER 1, 2020

of patients in the intent-to-treat population were able to feed orally without the need for feeding support

Four Keys to Success for Retail and Specialty-Lite Hub Services

Drug Channels

FEBRUARY 23, 2024

This Feed is for personal non-commercial use only. To learn more, register for Phil's upcoming webinar: Improving Access, Coverage, and GTN with a Digital Hub. Read on for Nicole’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Breaking Down Barriers: Helping Patients Get Therapies Quickly

Drug Channels

APRIL 26, 2024

This Feed is for personal non-commercial use only. To keep up with CoverMyMeds and all the action at Asembia, click here to sign up for daily recaps from Asembia. Read on for Kevin’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Copay Comes Full Circle: An Industry Ready for Disruption

Drug Channels

MARCH 8, 2024

This Feed is for personal non-commercial use only. To request an analysis of your copay savings program and learn more about Paysign’s patient affordability solutions, contact affordability@paysign.com or visit paysign.com/rx. Read on for Logan’s insights. All rights reserved.

The Four Key Factors to Evaluate When Insourcing vs. Outsourcing Patient Support Programs

Drug Channels

MARCH 15, 2024

This Feed is for personal non-commercial use only. To learn more, download the results from Cardinal Health’s survey: Insourcing and Outsourcing Trends for Patient Hubs. Read on for Josh’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

New Survey Reveals Manufacturers’ Patient Services Priorities for 2024

Drug Channels

FEBRUARY 9, 2024

This Feed is for personal non-commercial use only. Nasir also discusses how hub selection criteria are evolving. Read on for Nasir’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

STAT+: Pharmalittle: Walgreens won’t dispense abortion pills in several states; Lilly avoids paying Medicaid rebates with insulin price cuts

STAT

MARCH 6, 2023

… A two-part message is permeating the halls of medicine and the fabric of society, sliding into medical school lectures, pediatrician offices, happy hours, and social feeds: Obesity is a chronic biological disease — and it is treatable with a new class of medications , STAT explains. The

Medical Schools

Medical Schools Pharmaceutical Companies Pharmaceutical Companies

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents

Drug Channels

APRIL 16, 2024

This Feed is for personal non-commercial use only. Read on for DCI’s latest overview of the 2023 marketplace and revenues of the biggest market participants, along with key specialty pharmacy trends. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Specialty Pharmacies

Specialty Pharmacies Hospitals

Breastfeeding

RX Note

NOVEMBER 3, 2023

Weighing, measuring, and routine care for the infant should be delayed until the first feeding is completed. Principles of Breastfeeding New parents should be guided to Expect the newborn to wake easily often to feed. Feed every time the infant displays these feeding cues.

Hospitals

Hospitals Community Pharmacies

Drug Channels News Roundup, April 2024: CVS’s Humira Strategy, White Bagging “Savings,” IRA vs. Part D Plans, Walgreens Specialty Update, Pharmacies vs. GoodRx, and Oncology Fun

Drug Channels

APRIL 29, 2024

This Feed is for personal non-commercial use only. Join my nearly 55,000 LinkedIn followers for daily links to neat stuff. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Specialty Pharmacies

Specialty Pharmacies Biosimilars

Transforming Medication Access with the Next Generation of Patient Support Services

Drug Channels

DECEMBER 8, 2023

This Feed is for personal non-commercial use only. Read on for Kelly’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

New Report: How GoodRx Improves the Economics of Healthcare

Drug Channels

FEBRUARY 2, 2024

This Feed is for personal non-commercial use only. Click here to download the full report and learn more about partnering with GoodRx to drive patient access for your brand. Read on for Divya’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

The Drug Discount Ecosystem Needs Clarity in 2024 and Beyond

Drug Channels

FEBRUARY 16, 2024

This Feed is for personal non-commercial use only. To learn more about how the Inflation Reduction Act adds to challenges of drug discount programs, download Kalderos’ whitepaper: Operational Complexity and Evolving Challenges: What Drug Manufacturers Need to Know Now About Drug Discount Programs, the Inflation Reduction Act, and 340B.

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers

Drug Channels

APRIL 18, 2024

This Feed is for personal non-commercial use only. To learn more about GoodRx and its pharmacy partnerships, reach out to network@goodrx.com. Read on for Jim’s insights. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Brand-Name Drug Prices Fell for the Fifth Consecutive Year—And Plummeted After Adjusting for Inflation

Drug Channels

JANUARY 4, 2023

The data once again tell a different story than you might read in your favorite politician’s Twitter feed or misleading news reports. This Feed is for personal non-commercial use only. Time for the Drug Channels annual reality check on drug pricing. Even a purple gorilla professor understands these facts.

Drug Pricing

Repairing the Patient Journey: How Pharma Can Fix the Obvious–and Not So Obvious–Breaking Points of Nonadherence

Drug Channels

JANUARY 12, 2024

This Feed is for personal non-commercial use only. Learn more about EVERSANA’s solutions from this complimentary whitepaper: Repairing the Patient Journey: How Pharma Can Fix the Obvious–and Not So Obvious–Breaking Points of Nonadherence. Read on for the authors’ insights. All rights reserved.

How Centralized Prescription Fulfillment Allows Pharmacists to Better Help Patients

Drug Channels

OCTOBER 20, 2023

This Feed is for personal non-commercial use only. Read on for Melanie’s insights. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmacy Technician

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

APRIL 1, 2024

This Feed is for personal non-commercial use only. Tomorrow on Drug Channels , I’ll delve into the pros and cons of this new approach. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Drug Pricing

Drug Pricing Hospitals

Electronic Tablet Counter with Automated Feed Control

Pharmacy professionals invited to feed back on National Care Records Service

Trending Sources

A study says intermittent fasting is making people drop dead. Oh, come on

STAT+: In small study, baby aspirin cuts fat buildup in liver disease patients

Believe the hype? Mixed signals from AI’s impact on drug development

STAT+: He’s 19 months old and has one of the world’s rarest diseases. His parents are determined to find a cure.

Q&A: Why Dynamic Data Feeds are Critical for Successful Commercial Machine Learning Models

Opinion: Having a child with complex medical needs is hard enough. Navigating the health care system makes it worse

STAT+: New gene therapy, to be priced at $4.25 million, has already transformed children’s lives

STAT+: New weight loss drugs are changing the narrative on obesity, with a push from pharma

France’s biotech ecosystem is primed for growth – it’s time to feed it

STAT+: FDA cites cancer links in seeking to withdraw approval of antibiotic used in pigs

STAT+: UPMC, Advocate Aurora, Duke fighting lawsuits over use of Meta’s tracking tool

STAT+: Revenue cycle management company Waystar files for IPO

STAT+: NIH halts funding for Colombian research facilities accused of abusing animals

Opinion: What ‘The Bear’ can teach us about hospitality in medicine

Bracing for Impact: The Future of Hub, PAP, and Affordability Programs Under the Inflation Reduction Act

How Patient Engagement Can Reduce Brand Launch Risks

CVM Relaxes Its Stance on Claims for Food Ingredient; Opening the Door for (Some) Novel Food Ingredients

Navigating Market Access Challenges in Life Sciences Commercialization

Solving Access Barriers in Biomarker Testing: 5 Tips for Manufacturers

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Mapping the Vertical Integration of Insurers, PBMs, Specialty Pharmacies, and Providers: A May 2024 Update

Three Digital Intake Strategies For Eliminating Patient Enrollment Forms

Enteral Administration Reference

Pharmacists surveyed on prescription charges

Novartis' Zolgensma shows 'continued benefit' in SMA patients

Four Keys to Success for Retail and Specialty-Lite Hub Services

Breaking Down Barriers: Helping Patients Get Therapies Quickly

Copay Comes Full Circle: An Industry Ready for Disruption

The Four Key Factors to Evaluate When Insourcing vs. Outsourcing Patient Support Programs

New Survey Reveals Manufacturers’ Patient Services Priorities for 2024

STAT+: Pharmalittle: Walgreens won’t dispense abortion pills in several states; Lilly avoids paying Medicaid rebates with insulin price cuts

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents

Breastfeeding

Drug Channels News Roundup, April 2024: CVS’s Humira Strategy, White Bagging “Savings,” IRA vs. Part D Plans, Walgreens Specialty Update, Pharmacies vs. GoodRx, and Oncology Fun

Transforming Medication Access with the Next Generation of Patient Support Services

New Report: How GoodRx Improves the Economics of Healthcare

The Drug Discount Ecosystem Needs Clarity in 2024 and Beyond

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers

Brand-Name Drug Prices Fell for the Fifth Consecutive Year—And Plummeted After Adjusting for Inflation

Repairing the Patient Journey: How Pharma Can Fix the Obvious–and Not So Obvious–Breaking Points of Nonadherence

How Centralized Prescription Fulfillment Allows Pharmacists to Better Help Patients

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Stay Connected